STAT5B and T-cell large granular lymphocyte leukemia: Moreover, activating mutations in the SH2 domain of STAT5b have been identified in 2% of NK-LGL leukemia patients, who are characterized by a more aggressive and fatal clinical course, unlike typical LGL leukemia [73].